Novo Nordisk appoints new general manager for Ireland operation
Nina Hovland heads up Irish arm of Danish firm behind weight-loss-inducing drugs Wegovy and Ozempic
Novo Nordisk, the Danish company behind anti-obesity drug Wegovy and Ozempic, which is used to treat diabetes, has appointed a new general manager for Ireland as it ramps up its plans to develop a production facility in Dublin.
The new general manager is Nina Hovland, a former officer with the Royal Norwegian Airforce.
Hovland has previously worked as the obesity business unit director at Novo Nordisk, and has worked in the pharmaceutical industry since 2007.